# Safety and Efficacy Study of T-Guard to Treat Steroid-resistant Acute GVHD

> **NCT02027805** · PHASE1,PHASE2 · COMPLETED · sponsor: **Xenikos** · enrollment: 20 (actual)

## Conditions studied

- Graft vs Host Disease

## Interventions

- **BIOLOGICAL:** T-Guard

## Key facts

- **NCT ID:** NCT02027805
- **Lead sponsor:** Xenikos
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03-05
- **Primary completion:** 2016-09-07
- **Final completion:** 2016-11-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02027805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02027805, "Safety and Efficacy Study of T-Guard to Treat Steroid-resistant Acute GVHD". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02027805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*